Saturday 7 November 2026 Export URGN’s income statement to Excel — free account

Urogen Pharma

URGN Healthcare Biotechnology

Urogen Pharma’s revenue for fiscal 2025 (year ended December 2025) was $109.8 million, up 21.4% from fiscal 2024.

Revenue: +223.9%
EPS: +95.8%
Free cash flow: +64.0%
Total debt: +57.2%

Quarter to September 2026, against a year earlier

Revenue growth 5 yrs

24.81 0.92 −3.58%

Follow URGN

Alert me

Market cap: $1.3B
P/E: 0.0×
Fwd P/E: −161×
Dividend yield: —
F-score: 2/9
Altman Z: −5.16
Beneish M: −1.42
Dividend safety: n/a

Overview

	Sep '26	Jun '26	Mar '26	Dec '25	Older periods
Piotroski F-Score Full definition →	3	3	3	2	+8 more TTM periods Free account
ROE Full definition →	54.65%	86.49%	156.08%	268.63%
ROA Full definition →	(28.78%)	(42.33%)	(53.15%)	(63.14%)
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	(36.84%)	(56.08%)	(71.07%)	(109.45%)
Average Days of Receivables Full definition →	171.06	171.65	143.96	109.98
Free Cash Flow per Share Full definition →	(2.61)	(3.16)	(3.31)	(3.38)
Free Cash Flow Full definition →	(132.05)	(159.13)	(166.03)	(162.73)
Capital Expenditures Full definition →	(0.20)	(0.22)	(0.30)	(0.29)
Other line items
Cash ROIC Full definition →	(83.26%)	(94.40%)	(80.26%)	(114.59%)
Accounts Receivable Turnover Full definition →	3.65	3.48	3.74	4.11
Accounts Payable Turnover Full definition →	0.59	0.49	0.43	0.45
Inventory Turnover Full definition →	1.28	1.09	1.00	0.97
Average Days of Payables Full definition →	795.22	843.84	904.97	812.78
Days of Inventory on Hand Full definition →	426.93	519.45	535.65	482.80
Tax Rate Full definition →	0.02	0.00	(0.04)	0.00
Research and Development Expense of Revenue Full definition →	29.25%	32.46%	44.72%	61.12%
Selling, General and Administrative Expense of Revenue Full definition →	74.52%	93.71%	122.15%	141.27%
Share Based Compensation of Revenue Full definition →	7.73%	8.54%	9.62%	10.89%
Interest Coverage Full definition →	(1.92)	(4.11)	(7.00)	(8.14)
Operating CF/Net income Full definition →	2.01	1.63	1.24	1.06
Depreciation/Fixed assets Full definition →	(2.66)	(2.62)	(1.24)	(2.46)
Capex/Depreciation Full definition →	0.13	0.14	0.39	0.18
Revenue per Share Full definition →	4.95	3.75	2.80	2.28
Operating CF per Share Full definition →	(2.61)	(3.15)	(3.30)	(3.38)
Capex per Share Full definition →	0.00	0.00	(0.01)	(0.01)
Capex to Sales Full definition →	0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026

Stockrow Weekly